Filing Flows › Emmaus Life Sciences (EMMA) › Q2 2026 › vs Q2 2025
Emmaus Life Sciences (EMMA) Q2 2026 vs Q2 2025 (year over year)
Emmaus Life Sciences's revenue rose $3.5M (+124%) from $2.8M in Q2 2025 to $6.3M in Q2 2026. The biggest changes: Endari US +$3.7M (+158%); Endari International −$179K (-38%); Product and Service Other +$2K (+10%). Gross margin 94.6% against 94.7% (-0.1 pts).
Emmaus Life Sciences, Q2 2026: revenue $6.3M (+124% year over year), operating margin 60.0%, net earnings $1.3M, operating cash flow $1.7M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 94.6% | 94.7% | -0.1 pts |
| Operating margin | 60.0% | -13.1% | +73.1 pts |
| Net margin | 21.2% | -40.3% | +61.5 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Endari US | $6.0M | $2.3M | $3.7M | +158% |
| Endari International | $295K | $474K | −$179K | -38% |
| Product and Service Other | $22K | $20K | $2K | +10% |
| Revenue | $6.3M | $2.8M | $3.5M | +124% |
| Gross profit | $6.0M | $2.7M | $3.3M | +124% |
| Cost of revenue | $344K | $150K | $194K | +129% |
| Operating profit | $3.8M | −$370K | $4.2M | — |
| Operating expenses | $2.2M | $3.0M | −$854K | -28% |
| Pre-tax earnings | $1.3M | −$1.7M | $3.1M | — |
| Other expense, net | $2.5M | $1.4M | $1.1M | +81% |
| Research & development | $116K | $56K | $60K | +107% |
| Sales & marketing | $493K | $674K | −$181K | -27% |
| General & admin | $1.6M | $2.3M | −$733K | -32% |
| Income tax benefit | $1K | $590K | −$589K | -100% |
| Net earnings | $1.3M | −$1.1M | $2.5M | — |
| Depreciation | $14K | $4K | $10K | +250% |
| Working capital & other | $340K | −$1.8M | $2.1M | — |
| Operating cash flow | $1.7M | −$2.9M | $4.6M | — |
Questions
How much did Emmaus Life Sciences's revenue grow year over year in Q2 2026?
Emmaus Life Sciences's revenue rose $3.5M (+124%) from $2.8M in Q2 2025 to $6.3M in Q2 2026.
What drove Emmaus Life Sciences's revenue change in Q2 2026?
Endari US +$3.7M (+158%); Endari International −$179K (-38%); Product and Service Other +$2K (+10%).